Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Late Breaking Abstract - Value of the interleukin profile can be an objective standart for control  the tactics of managing patients with bronchiolitis

Pavel Berezhanskiy, Andrey Andjel, Aleksandr Malachov, Valeria Elagina
European Respiratory Journal 2021 58: OA1660; DOI: 10.1183/13993003.congress-2021.OA1660
Pavel Berezhanskiy
1Morozovskaya Children's Hospital, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bpvnever@gmail.com
Andrey Andjel
1Morozovskaya Children's Hospital, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandr Malachov
1Morozovskaya Children's Hospital, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valeria Elagina
1Morozovskaya Children's Hospital, Moscow, Russian Federation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Bronchiolitis is one of the most common lower respiratory tract infections that affects infants worldwide. In Europe, the estimated annual hospitalization rate for bronchiolitis in 2015 was 46.1 per 1,000 infants. Between 2005 and 2015, these figures grew by an average of 1.7% per year. Despite the high prevalence of bronchiolitis, it is a clinical diagnosis without a single international definition. Indicators of the interleukin profile can be an objective criterion for monitoring the management tactics of patients with bronchiolitis.

Materials and methods. The survey included 24 children with a clinically established diagnosis of bronchiolitis at the age from 1 to 7 months. All the patients in the acute stage of the disease were tested for the concentration of interleukins 6, 4 and 18 in blood.

Results: Children with grade 2 respiratory distress index, the average IL 6 is 4.2 pg / ml, IL 4 - 0.36 pg / ml, IL 18 - 1737.27 pg / ml, with with grade 1 respiratory distress index is average IL 6 - 10.07 pg / ml, IL 4 - 1.3 pg / ml, IL 18 - 1147.59 pg / ml, without respiratory failure IL 6 - 25.59 pg / ml, IL 4 - 2.39 pg / ml, IL 18 - 612.85 pg / ml. A positive correlation was found between IL18 and the degree of respiratory distress p + 0.86.

In patients with a diagnosis of bronchiolitis, depending on the severity of respiratory failure, pronounced changes in the cytokine profile: an increase in the concentration of Il-18 and a decrease in Il-4. These changes are an important objective label for choosing the tactics of managing these patients and predicting a possible deterioration of the degree of respiratory failure.

  • Children
  • Inflammation
  • Bronchiolitis

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, OA1660.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Late Breaking Abstract - Value of the interleukin profile can be an objective standart for control  the tactics of managing patients with bronchiolitis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Late Breaking Abstract - Value of the interleukin profile can be an objective standart for control  the tactics of managing patients with bronchiolitis
Pavel Berezhanskiy, Andrey Andjel, Aleksandr Malachov, Valeria Elagina
European Respiratory Journal Sep 2021, 58 (suppl 65) OA1660; DOI: 10.1183/13993003.congress-2021.OA1660

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Late Breaking Abstract - Value of the interleukin profile can be an objective standart for control  the tactics of managing patients with bronchiolitis
Pavel Berezhanskiy, Andrey Andjel, Aleksandr Malachov, Valeria Elagina
European Respiratory Journal Sep 2021, 58 (suppl 65) OA1660; DOI: 10.1183/13993003.congress-2021.OA1660
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Input of comorbidities to hospitalization of patients with COVID-19
  • SARS-CoV-2 seropositivity in asymptomatic frontline health workers in Ibadan, Nigeria
  • Exposure-response relationships of brensocatib in patients with non-cystic fibrosis bronchiectasis (NCFBE)
Show more Respiratory infections and bronchiectasis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society